Overview
Daniel Myszkowski practices practicing medicine in Bochum, Germany.
Mr. Myszkowski is highly rated in 1 condition, according to our data. His clinical expertise encompasses Hidradenitis Suppurativa and Atopic Dermatitis.
He is actively involved in clinical research, co-authoring 11 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Daniel Myszkowski
Is Daniel Myszkowski a top-rated expert for Hidradenitis Suppurativa?
MediFind is an objective health platform that identifies experts based on real-world data. Daniel Myszkowski is classified as an Advanced expert for Hidradenitis Suppurativa, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Daniel Myszkowski participate in research or clinical trials?
Yes. Daniel Myszkowski has published 11 articles and abstracts on conditions like Hidradenitis Suppurativa. You can view a list of Daniel Myszkowski's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Hidradenitis SuppurativaMr. Myszkowski isAdvanced. Learn about Hidradenitis Suppurativa.
- Experienced
- Atopic DermatitisMr. Myszkowski isExperienced. Learn about Atopic Dermatitis.